 |
市场调查报告书
商品编码
1741129
PCOS 诊断市场（按诊断测试类型、最终用户和地区）PCOS diagnostic Market, By Type of Diagnostic Test, By End-User, By Geography |
||||||
价格
简介目录
PCOS 诊断市场规模预计在 2025 年达到 39 亿美元，预计到 2032 年将达到 54.9 亿美元，2025 年至 2032 年的复合年增长率为 5%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 39亿美元 |
| 效能数据 | 从2020年到2024年 | 预测期 | 2025年至2032年 |
| 预测期：2025-2032年复合年增长率： | 5.00% | 2032年价值预测 | 54.9亿美元 |
多囊性卵巢症候群（PCOS）是一种荷尔蒙失调疾病，影响十分之一的育龄女性。它会导致月经不规则、生育能力下降以及脸部和身体毛髮增生。此疾病可导致月经不规则、排卵异常、雄性激素水平升高、卵巢增大、胰岛素抗性。据了解，全球有500万育龄女性受其影响。它还可能导致不孕症、类风湿性关节炎、高血压、心臟病和糖尿病等严重併发症。
市场动态：
多囊性卵巢症候群 (PCOS) 病例激增、盛行率上升以及女性对 PCOS 症状认识的提高，预计将在预测期内推动全球 PCOS 诊断市场的成长。肥胖、久坐的生活方式和荷尔蒙异常等其他因素也有望推动市场成长。
然而，治疗多囊性卵巢症候群（PCOS）药物的严格核准流程以及药物的副作用预计将在预测期内阻碍全球 PCOS 诊断市场的成长。
例如，根据世界卫生组织（WHO）2023年6月28日提供的数据，多囊性卵巢症候群（PCOS）是一个重大的公共卫生问题，也是影响育龄妇女最常见的荷尔蒙失调之一。据估计，该疾病影响全球8-13%的育龄妇女，高达70%的病例未被诊断。 PCOS在某些族群中的盛行率更高，这些族群通常会经历更多的併发症，尤其是与代谢紊乱相关的併发症。
本研究的主要特点
- 本报告对全球 PCOS 诊断市场进行了详细分析，并给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
- 它揭示了不同领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数列出了全球 PCOS 诊断市场的主要企业简介。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球 PCOS 诊断市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 相关人员将透过用于分析全球 PCOS 诊断市场的各种策略矩阵来做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 多囊性卵巢症候群（PCOS）盛行率不断上升
- 提高认识和早期诊断
- 诊断技术的进步
- 医疗成本上涨
- 限制因素
- 缺乏标准化的诊断标准
- 缺乏认识和诊断不足
- 成本和可负担性
- 机会
- 提高对多囊性卵巢卵巢治疗的认识
- 影响分析
- 主要亮点
- 监管情景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
第四章 PCOS 诊断市场-冠状病毒 (COVID-19) 大流行的影响
- COVID-19流行病学
- 供需侧分析
- 经济影响
5. PCOS 诊断市场（依诊断测试类型），2020 年至 2032 年
- 荷尔蒙测试
- 影像检查
- 血液检查
- 骨盆腔检查
- 基因检测
- 其他测试
6. PCOS 诊断市场（按最终用户划分），2020 年至 2032 年
- 医院和诊所
- 不孕不育诊所
- 居家照护环境
- 诊断实验室
7. PCOS 诊断市场（按地区划分），2020 年至 2032 年
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中部非洲
第八章 竞争态势
- Hoffmann-La Roche Ltd
- Abbott
- Quest Diagnostics
- Thermo Fisher Scientific Inc.
- Siemens Healthineers
- Bio-Rad Laboratories
- Hologic, Inc.
- Vitrolife
- Myriad Genetics, Inc.
- Ansh Labs
- Diagnostica Stago Inc.
- Beckman Coulter, Inc.
- Randox Laboratories Ltd.
- GE Healthcare
- PrivaPath Diagnostics
- Laboratory Corporation of America Holdings
- SRL Diagnostics
第九章 章节
- 调查方法
- 关于出版商
简介目录
Product Code: CMI5850
Pcos Diagnostic Market is estimated to be valued at USD 3.9 Bn in 2025 and is expected to reach USD 5.49 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.9 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.00% | 2032 Value Projection: | USD 5.49 Bn |
PCOS is a hormonal disorder that affects 1 in 10 women of childbearing age. It can cause irregular periods, trouble getting pregnant, and hair growth on the face and body. This condition results in irregular menstrual cycles, abnormal ovulation, high androgen levels, enlarged ovaries, and insulin resistance. It has been found to affect 5 million women of reproductive age globally. It also causes serious complications such as infertility, rheumatoid arthritis, high blood pressure, heart disease, and diabetes.
Market Dynamics:
Surging cases of the PCOS condition, increasing prevalence of PCOS, and increased awareness among women about its symptoms are expected to drive growth of the global PCOS diagnostic market over the forecast period. Other factors, including obesity, a sedentary lifestyle, and hormonal disorders, are also expected to drive the market's growth.
However, stringent regulatory approval processes for PCOS disease drugs and the side effects of treatment drugs are expected to hinder growth of the global PCOS diagnostic market over the forecast period.
For instance, on June 28, 2023, according to data provided by the World Health Organization, PCOS a significant public health problem and is one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age, and up to 70% of cases are undiagnosed worldwide. The prevalence of PCOS is higher among some ethnicities, and these groups often experience more complications, as in particular those related to metabolic problems.
Key features of the study:
- This report provides in-depth analysis of the global PCOS diagnostic market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global PCOS diagnostic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott, Quest Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Hologic, Inc., Vitrolife, Myriad Genetics, Inc., Ansh Labs, Diagnostica Stago Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., GE Healthcare, PrivaPath Diagnostics, Laboratory Corporation of America Holdings, SRL Diagnostics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global PCOS diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global PCOS diagnostic market
Detailed Segmentation:
- PCOS Diagnostic Market, By Type of Diagnostic Test:
- Hormone Test
- Imaging Tests
- Blood Tests
- Pelvic Examination
- Genetic Testing
- Other Tests
- PCOS Diagnostic Market, By End User:
- Hospitals and Clinics
- Fertility Clinics
- Homecare Settings
- Diagnostic Laboratories
- PCOS Diagnostic Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profile:
- F. Hoffmann-La Roche Ltd
- Abbott
- Quest Diagnostics
- Thermo Fisher Scientific, Inc.
- Siemens Healthineers
- Bio-Rad Laboratories
- Hologic, Inc.
- Vitrolife
- Myriad Genetics, Inc.
- Ansh Labs
- Diagnostica Stago Inc.
- Beckman Coulter, Inc.
- Randox Laboratories Ltd.
- GE Healthcare
- PrivaPath Diagnostics
- Laboratory Corporation of America Holdings
- SRL Diagnostics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market PCOS Diagnostic, By Type of Diagnostic Test
- Market PCOS Diagnostic, By End User
- Market PCOS Diagnostic, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing Prevalence of PCOS
- Growing Awareness and Early Diagnosis
- Technological Advancements in Diagnostics
- Rising Healthcare Expenditure
- Restraints
- Lack of Standardized Diagnostic Criteria
- Limited Awareness and under diagnosis
- Cost and Affordability
- Opportunities
- Growing awareness about polycystic ovarian syndrome treatment
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. PCOS Diagnostic Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. PCOS Diagnostic Market, By Type of Diagnostic Test, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hormone Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Imaging Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Blood Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pelvic Examination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Other Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. PCOS Diagnostic Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Fertility Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. PCOS Diagnostic Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vitrolife
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Myriad Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ansh Labs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Diagnostica Stago Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Randox Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PrivaPath Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Laboratory Corporation of America Holdings
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SRL Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
